Track topics on Twitter Track topics that are important to you
Austin, TX, March 02, 2017 --(PR.com)-- Sanitis Global (http://www.sanitisglobal.com) announced today that Andy Boisvert has joined the firm to further develop their growing portfolio of regional and national accounts. Andy Boisvert comes with a wealth of experience within the industry, having spent the last 3 years at Ansell Corporation where he was instrumental in acquiring and expanding numerous large corporate accounts. Joining in advance of the launch of Sanitis’ expanded portfolio of infection control, food safety, and environmental services products, Andy looks forward to building upon his past success providing organizations with effective solutions to optimize worker, product and customer safety.
Andy joins Sanitis as Director of Sales to continue Sanitis’s recent success providing innovative cutting edge infection prevention and food safety solutions for Health Care, Food Processing, and facilities to many of the top companies in North America and Europe. Andy comments “I am excited to start a new challenge within Sanitis and I look forward to working with the team to further expand their success with a truly remarkable portfolio of products. I am fortunate to be joining such a respected company that prides itself on innovative solutions for industries in which safety and sanitation are critical concerns.”
Harry Jarbath, Founder of Sanitis, said, “Andy’s wealth of experience and industry knowledge has already made him a key addition to the Sanitis family. We view his appointment as a sign of our commitment to being the leading company in our industry. Our new innovative products and the increasing demand from our customers led us to look for an addition to our team who will fit in with our ethos, and we are very fortunate that we were able to find someone of Andy ’s caliber to fulfill this role. I’m confident that Andy will play a key role in providing and implementing high quality solutions for our clients.”
Andy is based in Richmond, VA where he and his wife Kelly have resided for the past 10 years.
An exclusive sales and marketing firm for "next generation" infection control, disinfection, and green cleaning products for hospitals and clinics, food processing and food service facilities, and environmental services companies who are concerned about the spread of illnesses by cross-contamination. Sanitis’ “next generation” eco-friendly infection control and green cleaning solutions provide safe, clinically- and industry-proven solutions to the toughest and most critical challenges in preventing cross-contamination and the spread of disease in commercial and industrial environments, and we specialize in providing products to safely and effectively address the challenges in reducing Hospital Acquired Infections (HAIs) and meeting the requirements of the Food Safety and Modernization Act (FSMA). From persistent hand hygiene to people- and pet-safe commercial and hospital-grade disinfectants and green cleaners, their portfolio of products is especially well-suited to high-risk industries such as hospitals and health care and food processing and food service where cleanliness and sanitation are vital, and dangerous chemicals can be problematic. Janitorial services and building management firms will also appreciate that they can maintain green clean, healthy environments without the need for toxic cleaners and noxious fumes.
For more information on the company, please visit http://www.sanitisglobal.com
Director of Marketing and Advertising
Contact via Email
Read the full story here: http://www.pr.com/press-release/707132
Press Release Distributed by PR.com
Original Article: Sanitis Global Appoints New Director of SalesNEXT ARTICLE
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...